Cantabio Pharmaceuticals Inc. (CTBO: OTCQB) | Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimer's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease
(0)
(0)